Sayre Therapeutics Overview

  • Founded

  • 2015

Founded
  • Status

  • Private

  • Employees

  • 32

Employees
  • Latest Deal Type

  • Early Stage VC

  • Latest Deal Amount

  • $1M

  • Investors

  • 3

Sayre Therapeutics General Information

Description

Developer of a drug development platform designed to specialize in treating cancer and immunity-related diseases. The company's platform facilitates the development and registration of novel drugs, drug-delivery devices, and companion diagnostics, enabling pharmaceutical companies to commercialize proprietary drugs and medicines for the treatment of cancer.

Contact Information

Website
www.sayretherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • Number 91, 3rd Floor, G.R. Square
  • Amarjyothi Nagar HBCS Layout, Inner Ring road, Domlur
  • Bangalore, Karnataka 560071
  • India
+91 080 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sayre Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 05-Sep-2017 $1M 00.00 Completed Generating Revenue
2. Early Stage VC 04-Sep-2017 00.000 00.000 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 07-Apr-2015 $3.97M $3.97M 00.000 Completed Generating Revenue
To view Sayre Therapeutics’s complete valuation and funding history, request access »

Sayre Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Preference 00,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 000 00.000000 000.00 000.00 00 000.00 0.000
Preference 79,800 $0.156163 $48.41 $48.41 1x $48.41 34.7%
To view Sayre Therapeutics’s complete cap table history, request access »

Sayre Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a drug development platform designed to specialize in treating cancer and immunity-related diseases. The co
Drug Discovery
Bangalore, India
32 As of 2022
00.00
0000000000 0 00.00

000000

ptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat
0000 000000000
Delhi, India
00 As of 0000
00.000
00000000000 00.000

000000

o eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim v
000000000000000
Pune, India
0000 As of 0000
00.000
00000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sayre Therapeutics Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Invictus Oncology Venture Capital-Backed Delhi, India 00 00.000 00000000000 00.000
000000 Private Equity-Backed Pune, India 0000 00.000 00000000
00000 000000000000 Private Equity-Backed Ahmedabad, India 00000 000.00 00000000000 000.00
000 000000000000 Venture Capital-Backed Boston, MA 00 000.00 0000000000 0 000.00
To view Sayre Therapeutics’s complete competitors history, request access »

Sayre Therapeutics Executive Team (3)

Name Title Board Seat Contact Info
Shukrit Chimote Co-Founder, Chief Executive Officer & Board Member
Rajesh Sasidharan Head of Finance & Administration, Manager of Human resources & Administration & Board Member
You’re viewing 2 of 3 executive team members. Get the full list »

Sayre Therapeutics Board Members (3)

Name Representing Role Since
Mahendran Balachandran Accel Board Member 000 0000
Rajesh Sasidharan Sayre Therapeutics Head of Finance & Administration, Manager of Human resources & Administration & Board Member 000 0000
Shukrit Chimote Sayre Therapeutics Co-Founder, Chief Executive Officer & Board Member 000 0000
To view Sayre Therapeutics’s complete board members history, request access »

Sayre Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sayre Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
InnoVen Capital Lender/Debt Provider Minority 000 0000 000000 0
Aarin Capital Partners Venture Capital Minority 000 0000 000000 0
Accel Venture Capital Minority 000 0000 000000 0
To view Sayre Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial